Free Trial

This company has been marked as potentially delisted and may not be actively trading.

CAMP4 Therapeutics (CAMP) Competitors

CAMP4 Therapeutics logo

CAMP vs. KVHI, CMTL, AWRE, CSCO, QCOM, PANW, MSI, FFIV, JNPR, and CIEN

Should you be buying CAMP4 Therapeutics stock or one of its competitors? The main competitors of CAMP4 Therapeutics include KVH Industries (KVHI), Comtech Telecommunications (CMTL), Aware (AWRE), Cisco Systems (CSCO), QUALCOMM (QCOM), Palo Alto Networks (PANW), Motorola Solutions (MSI), F5 (FFIV), Juniper Networks (JNPR), and Ciena (CIEN). These companies are all part of the "communications equipment" industry.

CAMP4 Therapeutics vs. Its Competitors

CAMP4 Therapeutics (NASDAQ:CAMP) and KVH Industries (NASDAQ:KVHI) are both small-cap communications equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership.

In the previous week, KVH Industries had 1 more articles in the media than CAMP4 Therapeutics. MarketBeat recorded 1 mentions for KVH Industries and 0 mentions for CAMP4 Therapeutics. KVH Industries' average media sentiment score of 0.67 beat CAMP4 Therapeutics' score of 0.00 indicating that KVH Industries is being referred to more favorably in the news media.

Company Overall Sentiment
CAMP4 Therapeutics Neutral
KVH Industries Positive

73.7% of KVH Industries shares are held by institutional investors. 33.6% of CAMP4 Therapeutics shares are held by company insiders. Comparatively, 21.1% of KVH Industries shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

KVH Industries has higher revenue and earnings than CAMP4 Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CAMP4 Therapeutics$650K46.24-$51.79MN/AN/A
KVH Industries$113.83M0.93-$11.05M-$0.49-11.06

CAMP4 Therapeutics presently has a consensus target price of $16.50, indicating a potential upside of 1,006.64%. Given CAMP4 Therapeutics' stronger consensus rating and higher possible upside, equities analysts clearly believe CAMP4 Therapeutics is more favorable than KVH Industries.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CAMP4 Therapeutics
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.17
KVH Industries
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

CAMP4 Therapeutics has a net margin of 0.00% compared to KVH Industries' net margin of -8.72%. CAMP4 Therapeutics' return on equity of 0.00% beat KVH Industries' return on equity.

Company Net Margins Return on Equity Return on Assets
CAMP4 TherapeuticsN/A N/A N/A
KVH Industries -8.72%-4.47%-3.91%

Summary

CAMP4 Therapeutics beats KVH Industries on 9 of the 14 factors compared between the two stocks.

Get CAMP4 Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CAMP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CAMP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CAMP vs. The Competition

MetricCAMP4 TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$29.23M$2.96B$5.57B$9.02B
Dividend YieldN/A2.44%5.25%4.03%
P/E RatioN/A21.1627.2120.15
Price / Sales46.24260.59416.26185.35
Price / CashN/A41.8337.0657.97
Price / Book0.487.768.085.60
Net Income-$51.79M-$54.96M$3.16B$248.50M

CAMP4 Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CAMP
CAMP4 Therapeutics
3.1189 of 5 stars
$1.49
-60.1%
$16.50
+1,006.6%
+282.5%$29.23M$650K0.00644Gap Up
KVHI
KVH Industries
1.3325 of 5 stars
$5.38
-0.6%
N/A+22.2%$106.03M$113.83M-10.98650
CMTL
Comtech Telecommunications
3.7104 of 5 stars
$2.50
-3.8%
$6.00
+140.0%
-6.6%$76.43M$495.35M-0.251,990
AWRE
Aware
0.7166 of 5 stars
$1.83
flat
N/A+9.0%$38.60M$17.39M-7.3280
CSCO
Cisco Systems
4.7418 of 5 stars
$68.93
-0.6%
$69.53
+0.9%
+51.2%$274.71B$53.80B28.1390,400Positive News
Analyst Forecast
QCOM
QUALCOMM
4.9236 of 5 stars
$158.09
-2.5%
$188.00
+18.9%
-23.1%$178.11B$38.96B16.1049,000Positive News
Analyst Forecast
PANW
Palo Alto Networks
4.4856 of 5 stars
$201.42
-0.2%
$208.00
+3.3%
+22.6%$134.57B$8.03B115.1015,289Positive News
Insider Trade
MSI
Motorola Solutions
4.8196 of 5 stars
$426.20
+0.3%
$513.25
+20.4%
+7.0%$70.91B$10.96B35.5821,000Positive News
Analyst Forecast
FFIV
F5
4.0124 of 5 stars
$299.26
-0.3%
$282.56
-5.6%
+76.2%$17.24B$2.82B28.396,557Positive News
Analyst Forecast
JNPR
Juniper Networks
3.3779 of 5 stars
$39.95
flat
$40.00
+0.1%
N/A$13.36B$5.20B38.053,519
CIEN
Ciena
4.1551 of 5 stars
$80.11
-1.6%
$84.31
+5.2%
+70.0%$11.50B$4.01B111.268,657Analyst Upgrade

Related Companies and Tools


This page (NASDAQ:CAMP) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners